ncRNA name
hsa-miR-27a-3p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
BTG2
Cancer name
Breast Cancer
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Adriamycin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2
Tissue resource
human chemosensitive breast cancer cell lines MCF-7
human breast cancer adriamycin-resistant cell lines MCF-7/ADR
Experiment
None
Institute
American Type Culture Collection
Xinyu Biotechnology
Country
United States
China
Continent
North Amercian
Asia